Electrophysiological effects of lysophosphatidylcholine on HL-1 cardiomyocytes assessed with a microelectrode array system

Cellular Physiology and Biochemistry

Volumn 30, Issue 2, 2012, Pages 477-488

  Gizurarson, Sigfus ^a   Shao, Yangzhen ^a   Miljanovic, Azra ^a   Råmunddal, Truls ^a   Born, Jan ^a   Bergfeldt, Lennart ^a   Omerovic, Elmir ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NONE   (Sweden)

Author keywords

Electrophysiology; Field potential; HL 1 cardiomyocytes; Lysophosphatidylcholine; Microelectrode array system

Indexed keywords

1 PALMITOYLGLYCEROPHOSPHOCHOLINE; ATROPINE; HEPTANOL; ISOPRENALINE; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; ELECTRIC POTENTIAL; GAP JUNCTION; HEART ARRHYTHMIA; HEART BEAT; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; MICROCHIP ANALYSIS; MICROELECTRODE; MICROELECTRODE ARRAY MICROCHIP; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPONTANEOUSLY BEATING HL 1 HEART MUSCLE CELL;

EID: 84863505414     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000339029     Document Type: Article

References (32)

1. Moss AJ: Preventing heart failure and improving survival. N Engl J Med 2010;16;363:2456-2457
2. Yesil M: Management of arrhythmias during transport in patients with acute myocardial infarction. Anadolu Kardiyo. Berg 2007;7 Suppl 1:85-7.
3. Cascio WE, Yang H, Muller-Borer BJ, Johnson TA: Ischemia-induced arrhythmia: The role of connexins, gap junctions, and attendant changes in impulse propagation. J Electrocardiol 2005;38:55-59.
4. Watanabe M, Okada T: Lysophosphatidylcholine-induced myocardial damage is inhibited by pretreatment with poloxamer 188 in isolated rat heart. Mol Cell Biochem 2003;248:209-215.
5. Corr PB, Yamada KA, Creer MH, Sharma AD, Sobel BE: Lysophosphoglycerides and ventricular fibrillation early after onset of ischemia. J Mol Cell Cardiol 1987;19:S45-53.
6. Sobel BE, Corr PB, Robison AK, Goldstein RA, Witkowski FX, Klein MS: Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J Clin Invest 1978;62:546-553.
7. Kiyosue T, Arita M: Effects of lysophosphatidylcholine on resting potassium conductance of isolated guinea pig ventricular cells. Pfliigers Archiv 1986;406:296-302.
8. Undrovinas AI, Fleidervish IA, Makielski JC: Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circ Res 1992;71:1231-1241.
9. 2+ accumulation in rat cardiac myocytes. Am J Physiol 1983;244:H32-38.
10. 2+ channels in LPS-stimulated cardiomyocytes. J Mol Cell Cardiol 2010;48:131-139.
11. + stimulated atpase activity of rabbit and dog heart sarcolemma by lysophosphatidyl choline. Life Sci 1979;24:1869-1875.
12. Daleau P: Ethanol protects against lysophosphatidylcholine-induced uncoupling of cardiac cell pairs. Pflugers Arch 2002;445:55-59.
13. Hescheler J, Halbach M, Egert U, Lu ZJ, Bohlen H, Fleischmann BK, Reppel M: Determination of electrical properties of es cell-derived cardiomyocytes using meas. J Eectrocardiol 2004;37 Suppl:110-116.
14. Halbach M, Egert U, Hescheler J, Banach K: Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures. Cell Physiol Biochem 2003;13:271-284.
15. Reppel M, Igelmund P, Egert U, Juchelka F, Hescheler J, Drobinskaya I: Effect of cardioactive drugs on action potential generation and propagation in embryonic stem cell-derived cardiomyocytes. Cell Physiol Biochem 2007;19:213-224.
16. Claycomb WC, Lanson NA, Jr., Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ, Jr.: Hl-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 1998;95:2979-2984.
17. 2+ mechanism. Pediatric surgery international 2002;18:591-594.
18. Reppel M, Pillekamp F, Lu ZJ, Halbach M, Brockmeier K, Fleischmann BK, Hescheler J: Microelectrode arrays: A new tool to measure embryonic heart activity. J Electrocardiol 2004;37:S104-109.
19. Halbach M, Egert U, Hescheler J, Banach K: Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures. Cell Physiol Biochem 2003;13:271-284.
20. Banach K, Halbach MD, Hu P, Hescheler J, Egert U: Development of electrical activity in cardiac myocyte aggregates derived from mouse embryonic stem cells. Am J Physiol Heart Circ Physiol 2003;284:H2114-2123.
21. Kinnaird AA, Choy PC, Man RY: Lysophosphatidylcholine accumulation in the ischemic canine heart. Lipids 1988;23:32-35.
22. Corr PB, Yamada KA, Creer MH, Sharma AD, Sobel BE: Lysophosphoglycerides and ventricular fibrillation early after onset of ischemia. J Mol Cell Cardiol 1987;19:S45-53.
23. Liu SY, Yu CH, Hays JA, Panagia V, Dhalla NS: Modification of heart sarcolemmal phosphoinositide pathway by lysophosphatidylcholine. Biochim Biophys Acta 1997;1349:264-274.
24. Antzelevitch C, Burashnikov A: Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation. Ann N Y Acad Sci 2010;1188:78-86.
25. Gautier M, Zhang H, Fearon IM: Peroxynitrite formation mediates lpc-induced augmentation of cardiac late sodium currents. J Mol Cell Cardiol 2008;44:241-251.
26. + stimulated atpase activity of rabbit and dog heart sarcolemma by lysophosphatidyl choline. Life Sci 1979;24:1869-1875.
27. Hu YM, Zhang Z, Gao RB, Xu YQ: effect of lysophosphatidylcholine on the pacemaker current i(f) of sheep cardial purkinje fibers in ischemia-like condition. Sheng Li Xue Bao 1997;49:513-520.
28. Law JK, Yeung CK, Hofmann B, Ingebrandt S, Rudd JA, Offenhausser A, Chan M: The use of microelectrode array (mea) to study the protective effects of potassium channel openers on metabolically compromised hl-1 cardiomyocytes. Physiol meas 2009;30:155-167.
29. Bai Y, Wang J, Lu Y, Shan H, Yang B, Wang Z: Phospholipid lysophosphatidylcholine as a metabolic trigger and herg as an ionic pathway for extracellular k accumulation and "short qt syndrome" in acute myocardial ischemia. Cell Physiol Biochem 2007;20:417-428.
30. Daleau P: Lysophosphatidylcholine, a metabolite which accumulates early in myocardium during ischemia, reduces gap junctional coupling in cardiac cells. J Mol Cell Cardiol 1999;31:1391-1401.
31. 2+ handling and cell-to-cell coupling, key factors in prevention of sudden cardiac death. Can J Physiol Pharmacol 2009;87:1120-1129.
32. Salameh A, Dhein S: Adrenergic control of cardiac gap junction function and expression. Naunyn Schmiedebergs Arch Pharmacol 2011;383:331-346.